))
Dr. Chand Khanna | Comparative Oncology 2.0
Manage episode 440050369 series 3561919
תוכן מסופק על ידי ImpriMed, Inc.. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי ImpriMed, Inc. או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.
In this episode of the Veterinary Cancer Pioneers Podcast, Dr. Rachel Venable is joined by Dr. Chand Khanna, founder and board chair of Ethos Discovery, to explore the advancements in comparative oncology. Dr. Khanna delves into the concept of Comparative Oncology 2.0, discussing the increasing collaboration between human and animal health companies. They also examine the challenges of clinical trials, regulatory hurdles, and the future potential of comparative oncology in accelerating cancer drug development. Dr. Khanna highlights key examples of successful transactions between animal health and biotech companies. The conversation reveals how veterinary oncology can significantly contribute to human cancer treatment breakthroughs. Tune in for a deep dive into cutting-edge veterinary cancer research.
- Citation mentioned in the episode: Fenger JM, Eward W, Hendricks W, McNiel E, Johannes C, et al. (2020) Delivering Innovation to Oncology Drug Development Through Cancer Drug DISCO (Development Incentive Strategy using Comparative Oncology): Perspectives, Gaps and Solutions. Ann med clin Oncol 3: 120. DOI: 10.29011/AMCO-120.000120 (https://www.gavinpublishers.com/article/view/delivering-innovation-to-oncology-drug-development-through-cancer-drug-disco-development-incentive-strategy-using-comparative-oncology-perspectives-gaps-and-solutions)
📝Transcripts are available at https://www.imprimedicine.com/podcast.
To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile
Music Credit: Hazy by Beat Mekanik
18 פרקים
שתפו
